STAT Plus One of Indias biggest drug makers has a deeply troubling pattern of manufacturing problems

STAT Plus: One of India’s biggest drug makers has a ‘deeply troubling’ pattern of manufacturing problems

For the third time in four months, Lupin Pharmaceuticals, one of India’s biggest suppliers of generic drugs to foreign markets, has been admonished by the FDA.

More From BioPortfolio on "STAT Plus: One of India’s biggest drug makers has a ‘deeply troubling’ pattern of manufacturing problems"